- Home
- Publications
- Publication Search
- Publication Details
Title
Interleukin-27 Receptor Limits Atherosclerosis in
Ldlr
−/−
Mice
Authors
Keywords
-
Journal
CIRCULATION RESEARCH
Volume 111, Issue 10, Pages 1274-1285
Publisher
Ovid Technologies (Wolters Kluwer Health)
Online
2012-08-28
DOI
10.1161/circresaha.112.277525
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Interleukin-17 deficiency reduced vascular inflammation and development of atherosclerosis in Western diet-induced apoE-deficient mice
- (2012) Fumitake Usui et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Dynamic T cell–APC interactions sustain chronic inflammation in atherosclerosis
- (2012) Ekaterina K. Koltsova et al. JOURNAL OF CLINICAL INVESTIGATION
- Recent Advances on the Role of Cytokines in Atherosclerosis
- (2011) Hafid Ait-Oufella et al. ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY
- Role of Interleukin 17 in Inflammation, Atherosclerosis, and Vascular Function in Apolipoprotein E–Deficient Mice
- (2011) Meena S. Madhur et al. ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY
- Monocyte and Macrophage Dynamics During Atherogenesis
- (2011) Klaus Ley et al. ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY
- CCL17-expressing dendritic cells drive atherosclerosis by restraining regulatory T cell homeostasis in mice
- (2011) Christian Weber et al. JOURNAL OF CLINICAL INVESTIGATION
- Mycophenolate Mofetil Decreases Atherosclerotic Lesion Size by Depression of Aortic T-Lymphocyte and Interleukin-17–Mediated Macrophage Accumulation
- (2011) Sibylle von Vietinghoff et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Blockade of Interleukin-17A Results in Reduced Atherosclerosis in Apolipoprotein E–Deficient Mice
- (2010) Emily Smith et al. CIRCULATION
- Interleukin-17 and its target genes: mechanisms of interleukin-17 function in disease
- (2010) Reiko M. Onishi et al. IMMUNOLOGY
- IL-17A Is Proatherogenic in High-Fat Diet-Induced and Chlamydia pneumoniae Infection-Accelerated Atherosclerosis in Mice
- (2010) S. Chen et al. JOURNAL OF IMMUNOLOGY
- A Critical Function of Th17 Proinflammatory Cells in the Development of Atherosclerotic Plaque in Mice
- (2010) Q. Gao et al. JOURNAL OF IMMUNOLOGY
- IL-17-Mediated Monocyte Migration Occurs Partially through CC Chemokine Ligand 2/Monocyte Chemoattractant Protein-1 Induction
- (2010) S. Shahrara et al. JOURNAL OF IMMUNOLOGY
- Epstein-Barr Virus-Induced Gene-3 Is Expressed in Human Atheroma Plaques
- (2009) Sybille Kempe et al. AMERICAN JOURNAL OF PATHOLOGY
- Immune and Inflammatory Mechanisms of Atherosclerosis
- (2009) Elena Galkina et al. Annual Review of Immunology
- Attenuated atherosclerosis upon IL-17R signaling disruption in LDLr deficient mice
- (2009) T. van Es et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Chemokines in the vascular inflammatory response of atherosclerosis
- (2009) A. Zernecke et al. CARDIOVASCULAR RESEARCH
- Regulation of immune responses by interleukin-27
- (2009) Hiroki Yoshida et al. IMMUNOLOGICAL REVIEWS
- Inhibition of IL-17A Attenuates Atherosclerotic Lesion Development in ApoE-Deficient Mice
- (2009) C. Erbel et al. JOURNAL OF IMMUNOLOGY
- Myeloid cells in atherosclerosis: initiators and decision shapers
- (2009) Oliver Soehnlein et al. Seminars in Immunopathology
- The role of chemokines in recruitment of immune cells to the artery wall and adipose tissue
- (2009) Bonnie K. Surmi et al. VASCULAR PHARMACOLOGY
- Interleukin 27 attenuates collagen-induced arthritis
- (2008) W Niedbala et al. ANNALS OF THE RHEUMATIC DISEASES
- An overview of IL-17 function and signaling
- (2008) Sarah L. Gaffen CYTOKINE
- Advances in understanding the anti-inflammatory properties of IL-27
- (2008) J.S. Stumhofer et al. IMMUNOLOGY LETTERS
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExplorePublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More